Hypertension Notification Feature (HTNF) vs Zio AT ECG Monitoring System

Similar category, different focus. These tools serve overlapping but distinct needs. Comparability 65/100 Comparability is an AI-graded 0–100 score of how directly these two tools compete — higher means a more apples-to-apples comparison.
VS
by iRhythm Technologies, Inc.

AI Verdict

The Hypertension Notification Feature (HTNF) focuses on passively monitoring for patterns suggestive of hypertension, aiming for early patient awareness and engagement in blood pressure management. Conversely, the Zio AT ECG Monitoring System is a diagnostic tool for clinicians, providing continuous ECG monitoring to detect and report various arrhythmias. While both utilize AI and wearables for cardiac health, they address distinct medical conditions and serve different primary purposes in the patient care continuum.

Choose Hypertension Notification Feature (HTNF) if…

Choose the Hypertension Notification Feature (HTNF) if you are an individual seeking a passive, integrated tool for early awareness of potential hypertension patterns as part of your general wellness routine. This feature is ideal for proactive health management, prompting you to engage with a physician and monitor your blood pressure if suggestive patterns are detected, rather than for diagnosing an existing condition.

View Hypertension Notification Feature (HTNF) →

Choose Zio AT ECG Monitoring System if…

Choose the Zio AT ECG Monitoring System if a clinician requires continuous, long-term ECG data for the diagnosis or management of suspected or known cardiac arrhythmias. This system is designed for comprehensive, real-time mobile cardiac telemetry, providing detailed reports to aid in clinical decision-making regarding cardiac events.

View Zio AT ECG Monitoring System →

Reviewed by Pouyan Golshani, MD — Interventional Radiologist

Quick Comparison

Feature Hypertension Notification Feature (HTNF) Zio AT ECG Monitoring System
Pricing Unknown Contact for pricing
Deployment Mobile Cloud-based (data analytics and clinician portal)
BAA Available Unknown Yes AI-estimated
FDA Status Cleared AI-estimated Cleared AI-estimated
HIPAA Unknown Yes AI-estimated

Head-to-Head

AI-generated assessment across six dimensions based on each tool's documented features and compliance posture. Grounded in public data — not a substitute for hands-on evaluation.

Usability

Hypertension Notification Feature (HTNF)

Tool A, the Hypertension Notification Feature, is seamlessly integrated into the widely adopted Apple Watch and iPhone ecosystem, offering passive monitoring and familiar app-based interaction. This integration makes it highly accessible and exceptionally easy for users to adopt and utilize in their daily lives without additional hardware beyond a standard blood pressure cuff for confirmation.

Clinical Value

Zio AT ECG Monitoring System

While both tools are FDA-cleared, Tool B, the Zio AT ECG Monitoring System, offers more direct and definitive clinical value by providing continuous, AI-powered ECG monitoring for long-term arrhythmia detection and comprehensive diagnostic reports for clinicians. Tool A, conversely, serves as an early warning and screening tool for *possible* hypertension, prompting further action rather than providing a direct diagnosis.

Pricing & Value

Hypertension Notification Feature (HTNF)

Tool A's Hypertension Notification Feature is an integrated software component of compatible Apple Watch models and watchOS, meaning it is not a separately priced product or subscription. This offers significant value as an included feature for existing or new Apple Watch owners, whereas Tool B involves undisclosed service fees for monitoring and analysis.

Enterprise Readiness

Zio AT ECG Monitoring System

Tool B, the Zio AT system, is designed with enterprise readiness in mind, featuring cloud-based data analytics and a dedicated ZioSuite clinician portal for managing patients and interpreting reports. Its HIPAA compliance and BAA, combined with its focus on comprehensive clinician reporting, make it well-suited for integration into healthcare enterprise workflows. Tool A, while having a BAA, is primarily a consumer-facing tool integrated into personal devices.

Innovation

Tie

Both tools demonstrate significant innovation in their respective areas. Tool A innovatively uses AI to passively monitor optical heart sensor data on a mass-market consumer device for patterns suggestive of hypertension, offering a novel approach to population health screening. Tool B leverages a deep-learned AI algorithm for highly accurate and continuous arrhythmia detection over an extended period, representing a significant advancement in diagnostic cardiac monitoring.

Support & Docs

Zio AT ECG Monitoring System

Tool B, the Zio AT system, offers a more specialized and comprehensive support structure tailored for both patients and healthcare professionals, including dedicated Clinical Reference Manuals, a patient mobile app (MyZio) with FAQs and instructional videos, a dedicated customer care line, and a ZioSuite clinician portal. Tool A relies on Apple's general support channels and online Instructions for Use.

Feature-by-Feature

Detail beyond the Quick Comparison summary. For pricing, deployment, BAA, FDA, and HIPAA see the Overview tab.

Feature Hypertension Notification Feature (HTNF) Zio AT ECG Monitoring System
Company Apple iRhythm Technologies, Inc.
Primary Category Cardiology AI, Patient Engagement & Education, Wearables & Remote Monitoring (RPM) Cardiology AI, Wearables & Remote Monitoring (RPM)
Key Functionality Passive monitoring of blood vessel responses using optical heart sensor data over 30 days for patterns consistent with chronic hypertension, providing 'Possible Hypertension' notifications, prompting home blood pressure monitoring, and enabling logging in the Apple Health app. Continuous ECG recording for up to 14 days using a wearable patch, real-time data transmission, AI algorithm for arrhythmia detection, and comprehensive end-of-wear reports for clinicians.
Target Condition Hypertension (screening/early warning) Arrhythmia detection
Data Analysis Period 30-day data windows for analysis Up to 14 days of continuous recording
Intended User/Patient Population Adults aged 22 and over who have not been previously diagnosed with hypertension; not for use during pregnancy. Patients 18 years or older who may be asymptomatic or suffer from transient symptoms such as palpitations, shortness of breath, dizziness, light-headedness, pre-syncope, syncope, fatigue, or anxiety; not for critical care patients or those with known history of life-threatening arrhythmias.

Videos

Demos, reviews, and walkthroughs featuring Hypertension Notification Feature (HTNF) and Zio AT ECG Monitoring System.

Loading videos…
Videos need JavaScript to load. Search YouTube directly →

View all on YouTube

Frequently Asked Questions

The Hypertension Notification Feature (HTNF) is an early warning and screening tool for possible hypertension, passively monitoring heart sensor data to alert users to patterns suggestive of the condition. In contrast, the Zio AT ECG Monitoring System is designed for continuous, long-term ECG monitoring to detect and report arrhythmias.
The HTNF passively monitors blood vessel responses using optical heart sensor data over 30-day windows. The Zio AT system utilizes a wearable patch for continuous ECG recording for up to 14 days, with real-time data transmission via a wireless gateway.
The HTNF provides 'Possible Hypertension' notifications to users and enables logging of blood pressure measurements in the Apple Health app, which can be exported for physician review. Its advanced algorithm analyzes 30-day data for hypertension patterns. The Zio AT system uses an FDA-cleared deep-learned AI algorithm (ZEUS System) for arrhythmia detection and generates comprehensive end-of-wear reports for clinicians, accessible via a clinician portal.
With the HTNF, users are prompted to conduct 7-day home blood pressure monitoring with an upper-arm cuff and log measurements in the Apple Health app if they receive a 'Possible Hypertension' notification. For the Zio AT system, patients wear the Zio AT patch for continuous ECG recording and can use the MyZio patient mobile app for symptom logging and education.
Yes, the Hypertension Notification Feature is explicitly stated as not intended for diagnosis or treatment, but rather as an early warning and screening tool. The Zio AT system provides preliminary findings in its reports for the treating medical professional to make final clinical decisions, and it is not intended for critical care patients or situations requiring real-time, in-patient monitoring.

Backers

Who funded each tool's parent company.

Hypertension Notification Feature (HTNF)

AI Tool Finder
AI-powered search. Results may not be comprehensive.